Complement-Mediated Demyelination in Patients with IgM Monoclonal Gammopathy and Polyneuropathy
Salvatore Monaco(University of Verona), Nicola Rizzuto(University of Verona), Tom Eirik Mollnes(University of Oslo), E. Nardelli(University of Verona), Sérgio Ferrari(University of Verona), Emanuela Manfredini(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Francesco Tedesco(Federico II University Hospital), L Bonazzi(University of Verona), Giuseppe Moretto(University of Verona), Bruno Bonetti(Albert Einstein College of Medicine), Eduardo Nobile‐Orazio(Humanitas University)
Cited by 183
Related Papers
C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation
|Nature Communications|2016|294
Hashimoto's encephalopathy: epidemiologic data and pathogenetic considerations
|Journal of the Neurological Sciences|2003|258
Pain as a Nonmotor Symptom of Parkinson Disease
|Archives of Neurology|2008|243
Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions
|Journal of Neurology Neurosurgery & Psychiatry|2020|199
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Encephalitis Is a Cytokine Release Syndrome: Evidences From Cerebrospinal Fluid Analyses
|Clinical Infectious Diseases|2021|179